Jaime Contreras, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 12,000 shares at $39.37 ($474K) on 2014-03-03, disclosed to the SEC on 2014-03-04.
Scheduled sale ($474k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.79 | 3,919 | $156K | 32.9% |
| 2 | $39.37 | 650 | $26K | 5.4% |
| 3 | $39.37 | 4,831 | $190K | 40.1% |
| 4 | $39.38 | 600 | $24K | 5.0% |
| 5 | $39.38 | 2,000 | $79K | 16.6% |
| Total | $39.51 avg | 12,000 |
| $474K |
| 100% |
| Filing → |
| ABT | SELL | 2019-04-24 | $134K | — | Filing → |
| ABT | SELL | 2019-03-04 | $1.9M | — | Filing → |
| ABT | SELL | 2019-02-01 | $12.4M | — | Filing → |